OnCusp Therapeutics Revenue and Competitors
Employee Data
- OnCusp Therapeutics has 20 Employees.
- OnCusp Therapeutics grew their employee count by 0% last year.
OnCusp Therapeutics's People
| Name | Title | Email/Phone |
|---|
OnCusp Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.3M | 54 | 8% | N/A | N/A |
#2 | $354.3M | 461 | -2% | $567.1M | N/A |
#3 | $377.1M | 1427 | -8% | N/A | N/A |
#4 | $7.8M | 36 | 13% | N/A | N/A |
#5 | $5.4M | 25 | 14% | N/A | N/A |
#6 | $45M | 192 | 4% | N/A | N/A |
#7 | $6.8M | 27 | -4% | N/A | N/A |
#8 | $9.2M | 46 | 12% | N/A | N/A |
#9 | N/A | 694 | 46% | N/A | N/A |
#10 | $15.5M | 50 | -22% | N/A | N/A |
What Is OnCusp Therapeutics?
OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical and clinical programs, and creating value through global partnerships. The company is committed to accelerating the advancement of globally competitive oncology assets for patients.
keywords:N/A
N/A
Total Funding
20
Number of Employees
N/A
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 20 | -46% | $25.1M |
#2 | $1.7M | 20 | 11% | N/A |
#3 | $3.8M | 20 | -9% | N/A |
#4 | $2.5M | 20 | -5% | N/A |
#5 | $2.9M | 20 | N/A | N/A |